Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Support

This activity is supported by educational grants from Bristol Myers Squibb and Pfizer Alliance

Optimizing Outcomes in VTE Management: Collaborating Across the Continuum

Release Date: November 25, 2020
Expiration Date: May 31, 2021

Activity Overview

Venous thromboembolism (VTE) is a serious and underdiagnosed medical condition that manifests as deep vein thrombosis (DVT) and/or pulmonary embolism (PE) and can cause serious illness, disability, and death. It is important for primary care providers to recognize VTE in its early stages to effectively use evidence-based therapies to prevent serious complications, and to establish prophylactic care plans to prevent recurrent episodes.

This CME activity is the archived version of a November 13th, 2020 live webcast featuring experts versed in the management of VTE discussing current recommendations for treating people experiencing thrombosis in various care settings, coordinating among interdisciplinary health care teams, continuation of care post-VTE, and the impact of COVID-19 on VTE management.

Acknowledgement of Commercial Support

This activity is supported by educational grants from Bristol Myers Squibb and Pfizer Alliance

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.

Target Audience

This educational program is directed toward cardiologists and cardiology subspecialists. Nurse practitioners, physician assistants, nurses, and other health care professionals involved in the treatment and management of patients with VTE are also invited to participate.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Apply the latest recommendations for VTE management
  • Improve your understanding of current and emerging therapies
  • Learn from experts in the field of DVT/PE

Faculty, Staff, and Planners’ Disclosures

In accordance with ACCME Guidelines, PER® has identified and resolved all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.


Charles Vega, MD, FAAFP
Charles Vega, MD, FAAFP
Health Sciences Clinical Professor
Department of Family Medicine
Assistant Dean for Culture and Community Education
UC Irvine School of Medicine
Executive Director, UC Irvine Program in Medical Education for the Latino Community University of California, Irvine
Irvine, CA

Disclosures: Charles Vega, MD, FAAFP has no relevant financial relationships with commercial interests.

Executive Director of Interventional Cardiovascular Programs
Brigham and Women’s Hospital Heart & Vascular Center
Professor of Medicine, Harvard Medical School
Boston, MA

Disclosures: Research Funding: Amarin, Amgen, Astra-Zeneca, Bristol-Myers Squibb, Chiesi, Eisai, Ethicon, Forest Laboratories, Ironwood, Ischemix, Lilly, Medtronic, Pfizer, Roche, Sanofi-Aventis, The Medicines Company.

Elaine Hylek, MD, MPH
Elaine Hylek, MD, MPH
Professor, Department of Medicine
General Internal Medicine
Boston University School of Medicine
Boston, MA

Disclosures: Research Funding: Bristol Myers Squibb, Janssen; Consultant: Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Janssen, Pfizer.

Gregory Piazza, MD, MS
Gregory Piazza, MD, MS
Director, Vascular Medicine Section, Division of Cardiovascular Medicine
Associate Professor of Medicine, Harvard Medical School
Boston, MA

Disclosures: Research Funding: BMS/Pfizer Alliance, Janssen, Bayer, Portola, BSC; Consultant: Amgen, Prairie Education and Research Cooperative (PERC).

The staff of Physicians' Education Resource®, LLC (PER®) have no relevant financial relationships with commercial interests to disclose.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
Filter By